http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112020019853-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_168d138a9cb1c84ac007a6d0d8508a1a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F30-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16C20-70 |
| filingDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98dee60d8d115879cfcead193b9f452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383c4e91b1cdbaa778a334024918f526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f90dc070a5624a159c09c585495c0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442bde0fa78fb36df8457c9cc2ddd60e |
| publicationDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112020019853-A2 |
| titleOfInvention | METHOD AND SYSTEM FOR SIMULATION AND COMPUTATIONAL MODELING APPLIED TO CHARACTERIZATION AND / OR OPTIMIZATION OF DRUGS |
| abstract | METHOD AND SYSTEM FOR COMPUTATIONAL SIMULATION AND MODELING APPLIED TO DRUG CHARACTERIZATION AND / OR OPTIMIZATION.nA method for computer simulation and modeling applied to the characterization and / or optimization of drugs is described. The method comprises the step of storing on a computer platform 1 D1 digital data to model characteristics of an individual, D2 digital data to model characteristics of an animal, D3 digital data to model properties of chemical, and / or biological compounds, and / or drugs, D4 digital modeling data of D4 biological targets, D5 digital modeling data of disease characteristics and / or therapeutic areas, to which the drug is directed. The method then comprises a step of receiving information about selection and / or configuration, which can be entered by a user through an interface that can be connected to the Internet. The method processes, through computational platform 1, the types of selection, and / or definition, and / or configuration information, to develop a pharmacological and / or physiological M1 model (based on an individual's D1 digital modeling data, and / or D2 digital modeling data of an animal), an M2 chemical system model, and / or pharmacological, and / or biological, and / or therapeutic (based on D3 digital modeling data of chemical compounds, and / or biological, and / or drugs, and / or in the digital modeling data D4 of biological targets, and / or in the digital modeling data D5 of diseases and / or therapeutic areas), and an M3 model of screening and / or optimization ( based on D5 digital modeling data of disease characteristics and / or therapeutic areas, and also on the aforementioned D3 digital modeling data for chemical, and / or biological compounds, and / or drugs, and / or digital modeling data D4 of biological targets). Then, the selection and / or configuration information entered by the user is processed to prepare Din input configuration data for one or more computer modeling and / or simulation software programs included in the computer platform. The method then comprises the execution of a computer modeling and / or simulation, performed by one or more computer modeling and / or simulation software programs, based on the input configuration data Din, and based on the pharmacometric and / or M1 model. or physiological, in the M2 model of chemical system, and / or pharmacological, and / or biological, and in the M3 model of sorting and / or optimization, to obtain Dout output data from the modeling and / or computational simulation. Finally, the method comprises a step of processing the Dout output data from computer modeling and / or simulation, based on information I6 on the selection and configuration of one or more modeling and / or simulation output parameters, to report the results R of modeling and / or simulation requested in a format selected by the user, and a step of providing such simulation results requested through the user interface 4. |
| priorityDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.